GLP-1 amidation efficiency along the length of the intestine in mice, rats and pigs and in GLP-1 secreting cell lines

Peptides

Volumn 55, Issue , 2014, Pages 52-57

  Kuhre, Rune Ehrenreich ^a   Albrechtsen, Nicolai Wewer ^a   Windeløv, Johanne Agerlin ^a   Svendsen, Berit ^a   Hartmann, Bolette ^a   Holst, Jens Juul ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

GLP 1; GLP 1 measurement; Peptide's assays

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; INCRETIN;

AMIDATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASCENDING COLON; CARBOXY TERMINAL SEQUENCE; CECUM; CONTROLLED STUDY; DESCENDING COLON; DUODENUM; HORMONE BLOOD LEVEL; ILEUM; INTESTINE; JEJUNUM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT; RECTUM; SECRETORY CELL; SWINE; ANIMAL; C57BL MOUSE; CELL LINE; MALE; METABOLISM; PROTEIN PROCESSING; SPECIES DIFFERENCE; WISTAR RAT;

ANIMALS; CELL LINE; GLUCAGON-LIKE PEPTIDE 1; INTESTINES; MALE; MICE, INBRED C57BL; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS, WISTAR; SPECIES SPECIFICITY; SUS SCROFA;

EID: 84896768407     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2014.01.020     Document Type: Article

References (29)

1. K. Azuma, Z. Radikova, J. Mancino, F. Toledo, E. Thomas, and C. Kangani et al. Measurements of islet function and glucose metabolism with the dipeptidyl peptidase 4 inhibitor vildagliptin in patients with type 2 diabetes J Clin Endocrinol Metab 93 2008 459 464
2. A. Bruïne, W.M. Dinjens, M.J. Pijls, E.M. Linden, M.M. Rousch, and P. Moerkerk et al. NCI-H716 cells as a model for endocrine differentiation in colorectal cancer Virchows Archiv B: Cell Pathol 62 1992 311 320
3. C.F. Deacon, A.H. Johnsen, and J.J. Holst Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo J Clin Endocrinol Metab 80 1995 952 957
4. C.F. Deacon, L. Pridal, L. Klarskov, M. Olesen, and J.J. Holst Glucagon-like peptide 1 undergoes differential tissue-specific metabolism in the anesthetized pig Am J Physiol Endocrinol Metab 271 1996 E458 E464
5. D.J. Drucker, T. Jin, S.L. Asa, T.A. Young, and P.L. Brubaker Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line Mol Endocrinol 8 1994 1646 1655
6. P. Ehrlich, D. Tucker, S.L. Asa, P.L. Brubaker, and D.J. Drucker Inhibition of pancreatic proglucagon gene expression in mice bearing subcutaneous endocrine tumors Am J Physiol 1994 E662 E671
7. J. Eiki, K. Saeki, N. Nagano, T. Iino, M. Yonemoto, and Y. Takayenoki-Iino et al. A selective small molecule glucagon-like peptide-1 secretagogue acting via depolarization-coupled Ca(2+) influx J Endocrinol 201 2009 361 367
8. R. Eissele, R. Göke, S. Willemer, H.P. Harthus, H. Vermeer, and R. Arnold et al. Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man Eur J Clin Invest 22 1992 283 291
9. T. Fridolf, G. Bottcher, F. Sundler, and B. Ahrén GLP-1 and GLP-17-36 amide influences on basal and stimulated insulin and glucagon secretion in the mouse Pancreas 6 1991 208 215
10. F.M. Gribble, L. Williams, A.K. Simpson, and F. Reimann A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line Diabetes 52 2003 1147 1154
11. L. Hansen, C.F. Deacon, C. Orskov, and J.J. Holst Glucagon-like peptide-1-(7-36)amide is transformed to glucagon-like peptide-1-(9-36)amide by dipeptidyl peptidase IV in the capillaries supplying the L cells of the porcine intestine Endocrinology 140 1999 5356 5363
12. K.R. Hjøllund, C.F. Deacon, and J.J. Holst Dipeptidyl peptidase-4 inhibition increases portal concentrations of intact glucagon-like peptide-1 (GLP-1) to a greater extent than peripheral concentrations in anaesthetised pigs Diabetologia 54 2011 2206 2208
13. I. Kaji, S. Karaki, R. Tanaka, and A. Kuwahara Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide J Mol Histol 42 2011 27 38
14. T.J. Kieffer, C.H. McIntosh, and R.A. Pederson Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV Endocrinology 136 1995 3585 3596
15. S. Madsbad, U. Kielgast, M. Asmar, C. Deacon, S. Torekov, and J.J. Holst An overview of once-weekly glucagon-like peptide-1 receptor agonists-available efficacy and safety data and perspectives for the future Diabetes Obes Metab 13 2011 394 407
16. R. Mentlein, B. Gallwitz, and W.E. Schmidt Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum Eur J Biochem 214 1993 829 835
17. Milgram Sl, R.E. Mains, and B.A. Eipper COOH-terminal signals mediate the trafficking of a peptide processing enzyme in endocrine cells J Cell Biol 121 1993 23 36
18. S. Mojsov, G. Heinrich, I.B. Wilson, M. Ravazzola, L. Orci, and J.F. Habener Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing J Biol Chem 261 1986 11880 11889
19. S. Mojsov, M.G. Kopczynski, and J.F. Habener Both amidated and nonamidated forms of glucagon-like peptide I are synthesized in the rat intestine and the pancreas J Biol Chem 265 1990 8001 8008
20. K. Mortensen, L.L. Christensen, J.J. Holst, and C. Orskov GLP-1 and GIP are colocalized in a subset of endocrine cells in the small intestine Regul Pept 114 2003 189 196
21. M.A. Nauck, I. Weber, I. Bach, S. Richter, C. Orskov, and J. Holst et al. Normalization of fasting glycaemia by intravenous GLP-1 ([7-36 amide] or [7-37]) in type 2 diabetic patients Diabet Med 15 1998 937 945
22. C. Orskov, L. Rabenhøj, A. Wettergren, H. Kofod, and J.J. Holst Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans Diabetes 43 1994 535 539
23. C. Orskov, A. Wettergren, and J.J. Holst Biological effects and metabolic rates of glucagonlike peptide-1 7-36 amide and glucagonlike peptide-1 7-37 in healthy subjects are indistinguishable Diabetes 42 1993 656 661
24. L. Pridal, C.F. Deacon, O. Kirk, J. Christensen, R.D. Carr, and J.J. Holst Glucagon-like peptide-1(7-37) has a larger volume of distribution than glucagon-like peptide-1(7-36)amide in dogs and is degraded more quickly in vitro by dog plasma Eur J Metab Pharmacokinet 21 1996 51 59
25. J.F. Rehfeld Cellular peptide hormone synthesis and secretory pathways vol. 50 2010 Springer/Springer-Verlag Heidelberg, Dordrecht, London, New York/Berlin Heidelberg 125
26. R.A. Reimer Meat hydrolysate and essential amino acid-induced glucagon-like peptide-1 secretion, in the human NCI-H716 enteroendocrine cell line, is regulated by extracellular signal-regulated kinase1/2 and p38 mitogen-activated protein kinases J Endocrinol 191 2006 159 170
27. G. Rindi, G.N. Grant, Y. Yiangou, M.A. Ghatei, S.R. Bloom, and V.L. Bautch et al. Development of neuroendocrine tumors in the gastrointestinal tract of transgenic mice Am J Pathol 136 1990 15
28. T. Vilsboll, and J.J. Holst Incretins, insulin secretion and type 2 diabetes mellitus Diabeteologia 47 2004 357 366
29. A. Wettergren, L. Pridal, M. Wojdemann, and J.J. Holst Amidated and non-amidated glucagon-like peptide-1 (GLP-1): non-pancreatic effects (cephalic phase acid secretion) and stability in plasma in humans Regul Pept 16 1998 83 87